These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23679955)

  • 21. Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity Relationship.
    Figuerola-Asencio L; Morales P; Zhao P; Hurst DP; Sayed SS; Colón KL; Gómez-Cañas M; Fernández-Ruiz J; Croatt MP; Reggio PH; Abood ME; Jagerovic N
    ACS Med Chem Lett; 2023 Jan; 14(1):18-25. PubMed ID: 36655130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18.
    Schoeder CT; Mahardhika AB; Drabczyńska A; Kieć-Kononowicz K; Müller CE
    ACS Med Chem Lett; 2020 Oct; 11(10):2024-2031. PubMed ID: 33062188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold.
    Johansson H; Boesgaard MW; Nørskov-Lauritsen L; Larsen I; Kuhne S; Gloriam DE; Bräuner-Osborne H; Sejer Pedersen D
    J Med Chem; 2015 Nov; 58(22):8938-51. PubMed ID: 26516782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hybrid ortho/allosteric ligands for the adenosine A(1) receptor.
    Narlawar R; Lane JR; Doddareddy M; Lin J; Brussee J; Ijzerman AP
    J Med Chem; 2010 Apr; 53(8):3028-37. PubMed ID: 20345101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.
    Kotsikorou E; Madrigal KE; Hurst DP; Sharir H; Lynch DL; Heynen-Genel S; Milan LB; Chung TD; Seltzman HH; Bai Y; Caron MG; Barak L; Abood ME; Reggio PH
    Biochemistry; 2011 Jun; 50(25):5633-47. PubMed ID: 21534610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-ones.
    Meza-Aviña ME; Lingerfelt MA; Console-Bram LM; Gamage TF; Sharir H; Gettys KE; Hurst DP; Kotsikorou E; Shore DM; Caron MG; Rao N; Barak LS; Abood ME; Reggio PH; Croatt MP
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1827-1830. PubMed ID: 26916440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent and selective N-(4-sulfamoylphenyl)thiourea-based GPR55 agonists.
    Yrjölä S; Parkkari T; Navia-Paldanius D; Laitinen T; Kaczor AA; Kokkola T; Adusei-Mensah F; Savinainen JR; Laitinen JT; Poso A; Alexander A; Penman J; Stott L; Anskat M; Irving AJ; Nevalainen TJ
    Eur J Med Chem; 2016 Jan; 107():119-32. PubMed ID: 26575458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives.
    Matos MJ; Gaspar A; Kachler S; Klotz KN; Borges F; Santana L; Uriarte E
    J Pharm Pharmacol; 2013 Jan; 65(1):30-4. PubMed ID: 23215685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 6-arylcoumarins as novel nonsteroidal type progesterone antagonists: an example with receptor-binding-dependent fluorescence.
    Sakai H; Hirano T; Mori S; Fujii S; Masuno H; Kinoshita M; Kagechika H; Tanatani A
    J Med Chem; 2011 Oct; 54(20):7055-65. PubMed ID: 21916484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GPR55 and the vascular receptors for cannabinoids.
    Hiley CR; Kaup SS
    Br J Pharmacol; 2007 Nov; 152(5):559-61. PubMed ID: 17704825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
    Showalter VM; Compton DR; Martin BR; Abood ME
    J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1.
    Mo FM; Offertáler L; Kunos G
    Eur J Pharmacol; 2004 Apr; 489(1-2):21-7. PubMed ID: 15063151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and structure-activity relationships of 2-acylamino-4,6-diphenylpyridine derivatives as novel antagonists of GPR54.
    Kobayashi T; Sasaki S; Tomita N; Fukui S; Kuroda N; Nakayama M; Kiba A; Takatsu Y; Ohtaki T; Itoh F; Baba A
    Bioorg Med Chem; 2010 Jun; 18(11):3841-59. PubMed ID: 20457527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization.
    Rinaldi-Carmona M; Barth F; Congy C; Martinez S; Oustric D; Pério A; Poncelet M; Maruani J; Arnone M; Finance O; Soubrié P; Le Fur G
    J Pharmacol Exp Ther; 2004 Sep; 310(3):905-14. PubMed ID: 15131245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4'-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylase.
    Stefanachi A; Hanke N; Pisani L; Leonetti F; Nicolotti O; Catto M; Cellamare S; Hartmann RW; Carotti A
    Eur J Med Chem; 2015 Jan; 89():106-14. PubMed ID: 25462231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55.
    Schuelert N; McDougall JJ
    Neurosci Lett; 2011 Aug; 500(1):72-6. PubMed ID: 21683763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
    Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
    J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GPR18 and GPR55-related Ligands Serving as Antagonists or Agonists: Current Situation, Challenges and Perspectives.
    Zhang L; Fang Y; Hang S; Wu W; Sheng R; Guo R
    Med Chem; 2023; 19(9):838-847. PubMed ID: 37038675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virtual screening for selective allosteric mGluR1 antagonists and structure-activity relationship investigations for coumarine derivatives.
    Noeske T; Jirgensons A; Starchenkovs I; Renner S; Jaunzeme I; Trifanova D; Hechenberger M; Bauer T; Kauss V; Parsons CG; Schneider G; Weil T
    ChemMedChem; 2007 Dec; 2(12):1763-73. PubMed ID: 17868161
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.